title: De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy.
abstract: Denervation of skeletal muscles induces atrophy, preceded by changes in sarcolemma permeability of causes not yet completely understood. Here, we show that denervation-induced Evans blue dye uptake in vivo of fast, but not slow, myofibers was acutely inhibited by connexin (Cx) hemichannel/pannexin1 (Panx1) channel and purinergic ionotropic P2X7 receptor (P2X7R) blockers. Denervated myofibers showed up-regulation of Panx1 and de novo expression of Cx39, Cx43, and Cx45 hemichannels as well as P2X7Rs and transient receptor potential subfamily V, member 2, channels, all of which are permeable to small molecules. The sarcolemma of freshly isolated WT myofibers from denervated muscles also showed high hemichannel-mediated permeability that was slightly reduced by blockade of Panx1 channels or the lack of Panx1 expression, but was completely inhibited by Cx hemichannel or P2X7R blockers, as well as by degradation of extracellular ATP. However, inhibition of transient receptor potential subfamily V, member 2, channels had no significant effect on membrane permeability. Moreover, activation of the transcription factor NFκB and higher mRNA levels of proinflammatory cytokines (TNF-α and IL-1β) were found in denervated WT but not Cx43/Cx45-deficient muscles. The atrophy observed after 7 d of denervation was drastically reduced in Cx43/Cx45-deficient but not Panx1-deficient muscles. Therefore, expression of Cx hemichannels and P2X7R promotes a feed-forward mechanism activated by extracellular ATP, most likely released through hemichannels, that activates the inflammasome. Consequently, Cx hemichannels are potential targets for new therapeutic agents to prevent or reduce muscle atrophy induced by denervation of diverse etiologies.
authors.affiliation: Departamento de Fisiología, Pontificia Universidad Católica de Chile, Santiago 6513677, Chile.
authors.forename: Luis A
authors.initials: LA
authors.lastname: Cea
authors.forename: Bruno A
authors.initials: BA
authors.lastname: Cisterna
authors.forename: Carlos
authors.initials: C
authors.lastname: Puebla
authors.forename: Marina
authors.initials: M
authors.lastname: Frank
authors.forename: Xavier F
authors.initials: XF
authors.lastname: Figueroa
authors.forename: Christopher
authors.initials: C
authors.lastname: Cardozo
authors.forename: Klaus
authors.initials: K
authors.lastname: Willecke
authors.forename: Ramón
authors.initials: R
authors.lastname: Latorre
authors.forename: Juan C
authors.initials: JC
authors.lastname: Sáez
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D002463:Cell Membrane Permeability / Q000502:physiology*; D018031:Connexin 43 / Q000172:deficiency; D017630:Connexins / Q000378:metabolism*; D003714:Denervation; D005070:Evans Blue / Q000378:metabolism; D008297:Male; D008856:Microscopy, Fluorescence; D018482:Muscle, Skeletal / Q000294:innervation / Q000378:metabolism*; D009133:Muscular Atrophy / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012508:Sarcolemma / Q000378:metabolism*
chemical_list: D018031:Connexin 43; D017630:Connexins; D005070:Evans Blue
keywords: connexons; inflammation; membrane leakage; phosphorylated p65; purinergic receptors
references.citation: Mol Biol Cell. 2012 Jan;23(1):12-21
references.pmid: 22049022
references.citation: J Neurosci. 2005 Jan 19;25(3):566-76
references.pmid: 15659592
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1082-7
references.pmid: 15647354
references.citation: Free Radic Biol Med. 2007 Mar 1;42(5):627-35
references.pmid: 17291986
references.citation: J Biol Chem. 2001 Jun 8;276(23):20005-10
references.pmid: 11274168
references.citation: J Physiol. 1983 Dec;345:123-34
references.pmid: 6663495
references.citation: J Biol Chem. 2011 Dec 30;286(52):44480-90
references.pmid: 22033928
references.citation: Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11282-7
references.pmid: 22733741
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):684-7
references.pmid: 8133912
references.citation: Mol Biol Cell. 2008 Aug;19(8):3501-13
references.pmid: 18495870
references.citation: Exp Cell Res. 2011 May 1;317(8):1169-78
references.pmid: 21272575
references.citation: J Membr Biol. 1984;81(1):19-27
references.pmid: 6492126
references.citation: J Physiol. 2009 Dec 1;587(Pt 23):5739-52
references.pmid: 19805741
references.citation: J Exp Med. 2011 Nov 21;208(12):2449-63
references.pmid: 22084407
references.citation: J Gen Physiol. 1988 Jun;91(6):781-98
references.pmid: 2458429
references.citation: Am J Physiol. 1973 Jul;225(1):166-70
references.pmid: 4541360
references.citation: J Biol Chem. 2009 Jul 3;284(27):18143-51
references.pmid: 19416975
references.citation: Nucleic Acids Res. 2006;34(20):5863-71
references.pmid: 17062625
references.citation: Brain Res Brain Res Rev. 2004 Dec;47(1-3):174-88
references.pmid: 15572171
references.citation: Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1384-91
references.pmid: 21474431
references.citation: Pflugers Arch. 2005 Oct;451(1):193-203
references.pmid: 15909178
references.citation: Diabetes. 2009 Jan;58(1):174-84
references.pmid: 18984736
references.citation: Neuropharmacology. 2013 Dec;75:594-603
references.pmid: 23583931
references.citation: Eur J Pharmacol. 1997 May 1;325(2-3):237-43
references.pmid: 9163571
references.citation: J Pharmacol Exp Ther. 2006 Dec;319(3):1376-85
references.pmid: 16982702
references.citation: Bioessays. 2009 Sep;31(9):953-74
references.pmid: 19644918
references.citation: J Cell Sci. 2005 Jan 1;118(Pt 1):27-37
references.pmid: 15601660
references.citation: J Trauma. 2011 Feb;70(2):472-80
references.pmid: 20693912
references.citation: Pain. 2005 Dec 15;119(1-3):38-48
references.pmid: 16298067
references.citation: J Biol Chem. 2007 May 25;282(21):15894-902
references.pmid: 17395593
references.citation: Biochem Biophys Res Commun. 1997 Nov 26;240(3):612-7
references.pmid: 9398613
references.citation: EMBO J. 2006 Nov 1;25(21):5071-82
references.pmid: 17036048
references.citation: Nature. 2013 Mar 14;495(7440):223-6
references.pmid: 23467090
references.citation: J Clin Invest. 2008 Apr;118(4):1450-7
references.pmid: 18317591
references.citation: J Membr Biol. 2012 Aug;245(8):423-36
references.pmid: 22850938
references.citation: Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):495-500
references.pmid: 11756680
references.citation: Genesis. 2001 Jan;29(1):1-13
references.pmid: 11135457
references.citation: Muscle Nerve. 2010 Jul;42(1):70-7
references.pmid: 20544909
references.citation: Biochim Biophys Acta. 2013 Jan;1828(1):79-93
references.pmid: 22266266
references.citation: J Biol Chem. 2004 Oct 22;279(43):44749-55
references.pmid: 15304508